OIL

OPTISCAN FPO [OIL]
Optiscan Imaging Limited engages in the development, manufacture, and commercialisation of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows; InVivage, an intra-oral endomicroscope for oral imaging solutions; and ViewnVivo, a miniaturized in vivo imaging device for life sciences, pre-clinical and translational research. The company also provides InSpecta, a novel digital microscopic imaging device for veterinary medicine. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.
Technology · ASX Small Cap
$0.1450 -9.4%

Updated 3 Sep 2026 · Signals refresh every scan

Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when OIL triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track OIL — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • MACD momentum is losing steam
  • Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
  • Drifting lower — down 6.5% over the last 5 days
  • Lagging the Small Ords index — relative strength of 0.87, underperforming its peers
  • Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
  • Trading above the 200-day average — the long-term trend is on your side
  • Strong cash runway (8 quarters)
  • 4C filed 2026-07-30
  • Strong revenue growth (+125%)
  • CANSLIM S: Tight float (37%)
  • CANSLIM I: Institutional ownership (15%)
  • Sentiment is mixed — no strong consensus either way
  • Strong long-term momentum — up 55% over the past year (excluding last month)
  • Revenue growing at +125% — the top line is moving in the right direction
  • The bigger volume days are the up days — volume-weighted momentum is positive (2.01%/day)
  • RBA hiking (-3pts)

Risk Signals

  • Deeply negative margins (-193%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
Ask Scout AI about OIL
"What's driving OIL today?" "How does OIL compare to peers?" "Key risks for OIL?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Optiscan Initiates Head and Neck Cancer Study in the US
NONE Appendix 4G & Corporate Governance Statement
NONE Preliminary Final Report
LOW 2026 Annual Report
LOW Quarterly Activities/Appendix 4C Cash Flow Report

Recent ASX Announcements

2026-08-31 Optiscan Initiates Head and Neck Cancer Study in the US PRICE SENSITIVE
2026-08-24 Appendix 4G & Corporate Governance Statement
2026-08-24 2026 Annual Report
2026-08-24 Preliminary Final Report PRICE SENSITIVE
2026-07-30 Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE

Key Metrics

$161.8M
Market Cap
284K
Avg Volume
0.8x
Vol Ratio
$0.08 — $0.20
52-Week Range
N/A
Short Interest
8 qtrs
Cash Runway
-52.4%
ROE
-193.3%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandpassFloat: 37%
LLeader vs LaggardpassRS: 8
IInstitutional SponsorshippassInst: 15%
MMarket DirectionneutralNeutral

Sector: Technology

96 tickers in this sector

View all Technology signals →Browse all ASX tickers A–Z →
Related Tickers
SIS -20.0%AMS -16.7%ITS +16.7%EXT -16.7%FCT -14.3%
Compare:OIL vs SISOIL vs AMSOIL vs ITS
Scout Pro — Deeper Analysis for OIL
Try Pro free for 30 days
Share this analysis

Track OIL and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required